Who are Butyl Phthalate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Dipyrone, Metamizol, Yoshipyrin.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/dibutylphthalate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Butyl Phthalate — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Butyl Phthalate (dibutylphthalate) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: dibutylphthalate. Area: Pain.

unknown dibutylphthalate Transient receptor potential cation channel subfamily A member 1 Pain Live · refreshed every 30 min

Target snapshot

Butyl Phthalate (dibutylphthalate). Butyl Phthalate works by interacting with the transient receptor potential cation channel subfamily A member 1.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Butyl Phthalate TARGET	dibutylphthalate		unknown	dibutylphthalate	Transient receptor potential cation channel subfamily A member 1
Dipyrone	METAMIZOLE		marketed	metamizole	Transient receptor potential cation channel subfamily A member 1
Metamizol	Metamizol	Michał Borys	marketed		Transient receptor potential cation channel subfamily A member 1
Yoshipyrin	PROPYPHENAZONE		marketed	propyphenazone	Transient receptor potential cation channel subfamily A member 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (dibutylphthalate class)

· 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Butyl Phthalate — Competitive Intelligence Brief. https://druglandscape.com/ci/dibutylphthalate. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing